These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30768897)

  • 1. Chitosan Acetylation Degree Influences the Physical Properties of Polysaccharide Nanoparticles: Implication for the Innate Immune Cells Response.
    Furlani F; Sacco P; Decleva E; Menegazzi R; Donati I; Paoletti S; Marsich E
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9794-9803. PubMed ID: 30768897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery.
    Huang YC; Li RY
    Mar Drugs; 2014 Jul; 12(8):4379-98. PubMed ID: 25089950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate-Loaded Chitosan/Hyaluronan Nanoparticles: A Suitable Tool for Sustained Inhibition of ROS Release by Activated Neutrophils.
    Sacco P; Decleva E; Tentor F; Menegazzi R; Borgogna M; Paoletti S; Kristiansen KA; Vårum KM; Marsich E
    Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28869330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
    Wang T; Hou J; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Formation and Stability of Chitosan/Hyaluronan-Based Complex Coacervates.
    Furlani F; Parisse P; Sacco P
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32121005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
    Chen CH; Lin YS; Wu SJ; Mi FL
    Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
    Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
    Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
    Umerska A; Corrigan OI; Tajber L
    Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
    Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
    AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective effect of self-assembled low molecular weight Fucoidan-Chitosan nanoparticles.
    Wu SY; Parasuraman V; Hsieh-Chih-Tsai ; Arunagiri V; Gunaseelan S; Chou HY; Anbazhagan R; Lai JY; Prasad N R
    Int J Pharm; 2020 Apr; 579():119161. PubMed ID: 32081800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
    Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
    Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
    Wang F; Yang S; Yuan J; Gao Q; Huang C
    J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
    Umerska A; Paluch KJ; Inkielewicz-Stępniak I; Santos-Martinez MJ; Corrigan OI; Medina C; Tajber L
    Int J Pharm; 2012 Oct; 436(1-2):75-87. PubMed ID: 22814226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of chitosan nanoparticles carrying NF-κB/p65 antisense oligonucleotide in RAW264.7 macropghage stimulated by lipopolysaccharide.
    Ma L; Shen CA; Gao L; Li DW; Shang YR; Yin K; Zhao DX; Cheng WF; Quan DQ
    Colloids Surf B Biointerfaces; 2016 Jun; 142():297-306. PubMed ID: 26970817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of chitosan/hyaluronan colloidal polyelectrolyte complexes in physiological conditions.
    Wu D; Delair T
    Carbohydr Polym; 2015 Mar; 119():149-58. PubMed ID: 25563955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
    Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
    J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.